Rna virus-derived chimeric envelope protein and rna virus vector having same
AssigneeTokiwa-Bio Inc.
InventorsMahito NAKANISHI, Shiori MIZUTA
Life of this patent
Estimating the term…
Loading patent…
AssigneeTokiwa-Bio Inc.
InventorsMahito NAKANISHI, Shiori MIZUTA
Estimating the term…
The present invention addresses the problem of providing a chimeric envelope protein that pseudotypes a virus, and also providing efficient gene transfer and gene expression techniques to lymphocytes such as B cells, CD4 positive T cells, and CD8 positive T cells contained in peripheral blood and immortalized cells derived from these cells, said techniques being characterized by using an RNA virus vector having the aforesaid chimeric protein. In a gene transfer method using a single-stranded RNA virus vector such as a Sendai virus vector or a stealth RNA vector, the virus is pseudotyped by using, as the envelope proteins of viral particles, a chimeric F protein having a morbillivirus-derived F protein region and a chimeric H protein having a morbillivirus-derived H protein region.
A chimeric F protein of a paramyxovirus, which is any of the following (1) to (8):
A vector capable of expressing a chimeric F protein of a paramyxovirus, the vector being any one of the following (1) to (4):
Dependencies are inferred from the claim text.